

Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents.
Clovis Oncology's Net Promoter Score (NPS) is a 0 with 0% Promoters, 100% Passives, and 0% Detractors. Net Promoter Score tracks whether Clovis Oncology's customers would recommend using the product based on a scale of -100 to 100.
| 0% | Promoters |
|---|---|
| 100% | Passives |
| 0% | Detractors |
| Summary | Date | Score |
|---|---|---|
Jul 2021 0 | Jul 2021 | 0 |
Net Promoter Score (NPS) is a management tool that can be used to gauge the satisfaction of a firm's customer relationships. NPS has been widely adopted as a key metric often linked to the revenue potential of a company’s product or service. The metric is based on customer responses to the question: "On a scale of 0 to 10, how likely are you to recommend the product to a friend?"
Those who respond with a score of 9 to 10 are known as Promoters, and are widely associated with behaviors that create value, including actively encouraging others to use the product or service. Those who respond with a score of 7 or 8 are categorized as Passives, and they are believed to be less likely to exhibit the value-creation traits of Promoters having a largely neutral effect on other consumers. Detractors are those who fall in the score range of 0 to 6 and represent dissatisfied customers of the product sometimes actively recommending against using the product.
Clovis Oncology has an overall Product Quality score of 4 out of 5 stars rated by its users and customers.
Sign Up to unlock Clovis Oncology's overall Product Quality score rated by its users and customers.
Clovis Oncology’s product quality score is a 4 out of 5 as rated by its users and customers.